Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2014-12

AUTHORS

Giovanni Galati, Antonio De Vincentis, Umberto Vespasiani-Gentilucci, Paolo Gallo, Donatella Vincenti, Maria Carmela Solmone, Chiara Dell’Unto, Antonio Picardi

ABSTRACT

BACKGROUND: Some reports have documented the coexistence of Hepatitis B surfage Antigen (HBsAg) and anti-HBsAg antibodies (HBsAb) in patients with chronic hepatitis B (CHB), often in the absence of amino acid substitutions in the HBsAg sequences of the Hepatitis B Virus (HBV) genome able to explain an immunological escape variant.HBV genome has a very compact coding organization, with four partially overlapping open reading frames (ORFs). Because the reverse transcriptase region (rt) of HBV polymerase overlaps the HBsAg ORF, it is possible that some mutations in the HBsAg region correspond to mutations in the rt ORF, conferring resistance to current antiviral therapies. This unique case explores the response to antiviral therapies of a CHB with concurrent HBsAg and HBsAb positivity, and analyse the clinical implications of possible mutations in rt and HBsAg ORFs. CASE PRESENTATION: Here we describe the case of a 59 year-old Italian man suffering from Hepatitis B envelope Antigen (HBeAg) positive CHB with concurrent HBsAb positivity. By ultra-deep pyro-sequencing (UDPS) technique, mutations conferring immunological escape or resistance to antiviral therapies were found neither in HBsAg nor in HBV rt ORFs, respectively. The patient was unsuccessfully treated with interferon, adefovir monotherapy and adefovir plus entecavir combination. Surprisingly, during entecavir plus tenofovir combination, anti-HBe seroconversion and HBsAg loss were observed, while the titer of HBsAb persisted. CONCLUSIONS: Concurrent HBsAg/HBsAb positivity in active CHB is a clinical and virological dilemma. In this setting, there are not consistent data about the response to conventional therapies and the immunological balance between host and virus remains so far unexplained. This is, to our knowledge, the first case described of a CHB with HBsAg/HBsAb positivity, wild type for clinically relevant mutations in HBsAg and rt ORFs, successfully treated with a combination of nucleot(s)ide analogues (NAs). More... »

PAGES

94

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1471-230x-14-94

DOI

http://dx.doi.org/10.1186/1471-230x-14-94

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1042212885

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24885182


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1108", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical Microbiology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adenine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antiviral Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Guanine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hepatitis B Antibodies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hepatitis B Surface Antigens", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hepatitis B e Antigens", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hepatitis B, Chronic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Interferon-alpha", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Organophosphonates", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Recombinant Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tenofovir", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Failure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Viral Load", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Universit\u00e0 Campus Bio-Medico", 
          "id": "https://www.grid.ac/institutes/grid.9657.d", 
          "name": [
            "Clinical Medicine and Hepatology Unit, Campus Bio Medico University of Rome, 200, Alvaro Del Portillo Street, 00128, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Galati", 
        "givenName": "Giovanni", 
        "id": "sg:person.01020754724.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01020754724.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Universit\u00e0 Campus Bio-Medico", 
          "id": "https://www.grid.ac/institutes/grid.9657.d", 
          "name": [
            "Clinical Medicine and Hepatology Unit, Campus Bio Medico University of Rome, 200, Alvaro Del Portillo Street, 00128, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "De Vincentis", 
        "givenName": "Antonio", 
        "id": "sg:person.0755456160.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0755456160.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Universit\u00e0 Campus Bio-Medico", 
          "id": "https://www.grid.ac/institutes/grid.9657.d", 
          "name": [
            "Clinical Medicine and Hepatology Unit, Campus Bio Medico University of Rome, 200, Alvaro Del Portillo Street, 00128, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vespasiani-Gentilucci", 
        "givenName": "Umberto", 
        "id": "sg:person.0736357351.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0736357351.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Universit\u00e0 Campus Bio-Medico", 
          "id": "https://www.grid.ac/institutes/grid.9657.d", 
          "name": [
            "Clinical Medicine and Hepatology Unit, Campus Bio Medico University of Rome, 200, Alvaro Del Portillo Street, 00128, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gallo", 
        "givenName": "Paolo", 
        "id": "sg:person.01004120050.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01004120050.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani", 
          "id": "https://www.grid.ac/institutes/grid.419423.9", 
          "name": [
            "National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d, 292 Portuense Street, 00149, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vincenti", 
        "givenName": "Donatella", 
        "id": "sg:person.01174604772.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174604772.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani", 
          "id": "https://www.grid.ac/institutes/grid.419423.9", 
          "name": [
            "National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d, 292 Portuense Street, 00149, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Solmone", 
        "givenName": "Maria Carmela", 
        "id": "sg:person.01320704465.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320704465.59"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Universit\u00e0 Campus Bio-Medico", 
          "id": "https://www.grid.ac/institutes/grid.9657.d", 
          "name": [
            "Clinical Medicine and Hepatology Unit, Campus Bio Medico University of Rome, 200, Alvaro Del Portillo Street, 00128, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dell\u2019Unto", 
        "givenName": "Chiara", 
        "id": "sg:person.01272064356.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272064356.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Universit\u00e0 Campus Bio-Medico", 
          "id": "https://www.grid.ac/institutes/grid.9657.d", 
          "name": [
            "Clinical Medicine and Hepatology Unit, Campus Bio Medico University of Rome, 200, Alvaro Del Portillo Street, 00128, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Picardi", 
        "givenName": "Antonio", 
        "id": "sg:person.01046155143.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046155143.25"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.4065/82.8.967", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001585719"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1386-6532(02)00049-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016035813"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.virol.2007.05.012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016357280"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.88.10.4186", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019592616"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/jvi.02011-08", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021168978"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1086/513200", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022757619"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/hep.510300511", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026634474"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa020681", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027660106"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0168-8278(95)80226-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037903619"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/jvi.80.6.2968-2975.2006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037926878"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1478-3231.2007.01480.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042066104"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2893.1999.00160.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051062831"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2893.1999.00160.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051062831"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/j.gastro.2012.05.037", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053089951"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-119-4-199308150-00011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073697674"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077654954", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1081694921", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-12", 
    "datePublishedReg": "2014-12-01", 
    "description": "BACKGROUND: Some reports have documented the coexistence of Hepatitis B surfage Antigen (HBsAg) and anti-HBsAg antibodies (HBsAb) in patients with chronic hepatitis B (CHB), often in the absence of amino acid substitutions in the HBsAg sequences of the Hepatitis B Virus (HBV) genome able to explain an immunological escape variant.HBV genome has a very compact coding organization, with four partially overlapping open reading frames (ORFs). Because the reverse transcriptase region (rt) of HBV polymerase overlaps the HBsAg ORF, it is possible that some mutations in the HBsAg region correspond to mutations in the rt ORF, conferring resistance to current antiviral therapies. This unique case explores the response to antiviral therapies of a CHB with concurrent HBsAg and HBsAb positivity, and analyse the clinical implications of possible mutations in rt and HBsAg ORFs.\nCASE PRESENTATION: Here we describe the case of a 59 year-old Italian man suffering from Hepatitis B envelope Antigen (HBeAg) positive CHB with concurrent HBsAb positivity. By ultra-deep pyro-sequencing (UDPS) technique, mutations conferring immunological escape or resistance to antiviral therapies were found neither in HBsAg nor in HBV rt ORFs, respectively. The patient was unsuccessfully treated with interferon, adefovir monotherapy and adefovir plus entecavir combination. Surprisingly, during entecavir plus tenofovir combination, anti-HBe seroconversion and HBsAg loss were observed, while the titer of HBsAb persisted.\nCONCLUSIONS: Concurrent HBsAg/HBsAb positivity in active CHB is a clinical and virological dilemma. In this setting, there are not consistent data about the response to conventional therapies and the immunological balance between host and virus remains so far unexplained. This is, to our knowledge, the first case described of a CHB with HBsAg/HBsAb positivity, wild type for clinically relevant mutations in HBsAg and rt ORFs, successfully treated with a combination of nucleot(s)ide analogues (NAs).", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/1471-230x-14-94", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1024942", 
        "issn": [
          "1471-230X"
        ], 
        "name": "BMC Gastroenterology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "14"
      }
    ], 
    "name": "Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination", 
    "pagination": "94", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "c914dccf7b5d1a64d33cc06edf7dff28d195601d7d3835e187c1bf8d1984db86"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24885182"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100968547"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1471-230x-14-94"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1042212885"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1471-230x-14-94", 
      "https://app.dimensions.ai/details/publication/pub.1042212885"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T02:20", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8700_00000551.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2F1471-230X-14-94"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1471-230x-14-94'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1471-230x-14-94'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1471-230x-14-94'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1471-230x-14-94'


 

This table displays all metadata directly associated to this object as RDF triples.

238 TRIPLES      21 PREDICATES      63 URIs      39 LITERALS      27 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1471-230x-14-94 schema:about N0620409dc955433cbb699114e2257650
2 N090e25966be84984a9f789811d21b104
3 N0cce9044379a42c5b5480e54c7ad0fd7
4 N219254e490a4469ba3a3ec5efdd1c474
5 N2dfcc3216d5a4b87a8dbab3a7547a74c
6 N3af2d277df004b8883dd27863a566a76
7 N4a5cda1a25614ad4b01d4924c7597b8d
8 N55c25ff4823f46178bff8013907dcaa1
9 N6a3f1f9a588f4027909f82c0a13988b0
10 N907ecf4bc67a4d91a176de38bea2a7a4
11 N915f2d8296cf4d82b8961cba8a745862
12 Naa547ca852f7475fb360e20c3d2a6de1
13 Nb33fa6e1151b4b99ad3c7fcba24fd86b
14 Nb4f8170048ff44e39824c4185b9c9b13
15 Nbcfd8d0c0871485da08831b0ef39c0f2
16 Nca3672b60ab449b09a1cf646475e8eef
17 Nd3c2102d14014c439fe818fdcd66befb
18 Nfe1c4ab4854b45b0b6e8614e027d2aa9
19 anzsrc-for:11
20 anzsrc-for:1108
21 schema:author N3fb5cf54dd4040f6a6c6f8358deaca91
22 schema:citation https://app.dimensions.ai/details/publication/pub.1077654954
23 https://app.dimensions.ai/details/publication/pub.1081694921
24 https://doi.org/10.1002/hep.510300511
25 https://doi.org/10.1016/0168-8278(95)80226-6
26 https://doi.org/10.1016/j.virol.2007.05.012
27 https://doi.org/10.1016/s1386-6532(02)00049-5
28 https://doi.org/10.1046/j.1365-2893.1999.00160.x
29 https://doi.org/10.1053/j.gastro.2012.05.037
30 https://doi.org/10.1056/nejmoa020681
31 https://doi.org/10.1073/pnas.88.10.4186
32 https://doi.org/10.1086/513200
33 https://doi.org/10.1111/j.1478-3231.2007.01480.x
34 https://doi.org/10.1128/jvi.02011-08
35 https://doi.org/10.1128/jvi.80.6.2968-2975.2006
36 https://doi.org/10.4065/82.8.967
37 https://doi.org/10.7326/0003-4819-119-4-199308150-00011
38 schema:datePublished 2014-12
39 schema:datePublishedReg 2014-12-01
40 schema:description BACKGROUND: Some reports have documented the coexistence of Hepatitis B surfage Antigen (HBsAg) and anti-HBsAg antibodies (HBsAb) in patients with chronic hepatitis B (CHB), often in the absence of amino acid substitutions in the HBsAg sequences of the Hepatitis B Virus (HBV) genome able to explain an immunological escape variant.HBV genome has a very compact coding organization, with four partially overlapping open reading frames (ORFs). Because the reverse transcriptase region (rt) of HBV polymerase overlaps the HBsAg ORF, it is possible that some mutations in the HBsAg region correspond to mutations in the rt ORF, conferring resistance to current antiviral therapies. This unique case explores the response to antiviral therapies of a CHB with concurrent HBsAg and HBsAb positivity, and analyse the clinical implications of possible mutations in rt and HBsAg ORFs. CASE PRESENTATION: Here we describe the case of a 59 year-old Italian man suffering from Hepatitis B envelope Antigen (HBeAg) positive CHB with concurrent HBsAb positivity. By ultra-deep pyro-sequencing (UDPS) technique, mutations conferring immunological escape or resistance to antiviral therapies were found neither in HBsAg nor in HBV rt ORFs, respectively. The patient was unsuccessfully treated with interferon, adefovir monotherapy and adefovir plus entecavir combination. Surprisingly, during entecavir plus tenofovir combination, anti-HBe seroconversion and HBsAg loss were observed, while the titer of HBsAb persisted. CONCLUSIONS: Concurrent HBsAg/HBsAb positivity in active CHB is a clinical and virological dilemma. In this setting, there are not consistent data about the response to conventional therapies and the immunological balance between host and virus remains so far unexplained. This is, to our knowledge, the first case described of a CHB with HBsAg/HBsAb positivity, wild type for clinically relevant mutations in HBsAg and rt ORFs, successfully treated with a combination of nucleot(s)ide analogues (NAs).
41 schema:genre research_article
42 schema:inLanguage en
43 schema:isAccessibleForFree true
44 schema:isPartOf N193df1b7263242cb81e050bfea73bab3
45 N810721aef8c94943bb812a2bd9b20da5
46 sg:journal.1024942
47 schema:name Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination
48 schema:pagination 94
49 schema:productId N0e3137bae70542288e20aaa1c79d6a22
50 N382940bf12c54a138b52285e17ed9e1a
51 N6d445c7a46d54f6b8ff27577935ef673
52 N6ef7e046670b49a69f06fde2b5402550
53 N8a3736451c1f40a3b05958de2bf09174
54 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042212885
55 https://doi.org/10.1186/1471-230x-14-94
56 schema:sdDatePublished 2019-04-11T02:20
57 schema:sdLicense https://scigraph.springernature.com/explorer/license/
58 schema:sdPublisher N37f920a0d34441f291b84cfb82fcb8db
59 schema:url http://link.springer.com/10.1186%2F1471-230X-14-94
60 sgo:license sg:explorer/license/
61 sgo:sdDataset articles
62 rdf:type schema:ScholarlyArticle
63 N0620409dc955433cbb699114e2257650 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
64 schema:name Viral Load
65 rdf:type schema:DefinedTerm
66 N090e25966be84984a9f789811d21b104 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
67 schema:name Middle Aged
68 rdf:type schema:DefinedTerm
69 N0b342ab98d3d49cfa1c40118042b9266 rdf:first sg:person.01004120050.35
70 rdf:rest N3c34ab4894aa4ababf6a7674b5e26016
71 N0cce9044379a42c5b5480e54c7ad0fd7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Humans
73 rdf:type schema:DefinedTerm
74 N0e3137bae70542288e20aaa1c79d6a22 schema:name pubmed_id
75 schema:value 24885182
76 rdf:type schema:PropertyValue
77 N193df1b7263242cb81e050bfea73bab3 schema:issueNumber 1
78 rdf:type schema:PublicationIssue
79 N219254e490a4469ba3a3ec5efdd1c474 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Treatment Failure
81 rdf:type schema:DefinedTerm
82 N2dfcc3216d5a4b87a8dbab3a7547a74c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Tenofovir
84 rdf:type schema:DefinedTerm
85 N2e2230583c0249f4b61dff65a602a9eb rdf:first sg:person.01272064356.26
86 rdf:rest N3fcbfb95feb64083bc79b4ea66957b5a
87 N37f920a0d34441f291b84cfb82fcb8db schema:name Springer Nature - SN SciGraph project
88 rdf:type schema:Organization
89 N382940bf12c54a138b52285e17ed9e1a schema:name nlm_unique_id
90 schema:value 100968547
91 rdf:type schema:PropertyValue
92 N3af2d277df004b8883dd27863a566a76 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Adenine
94 rdf:type schema:DefinedTerm
95 N3c34ab4894aa4ababf6a7674b5e26016 rdf:first sg:person.01174604772.21
96 rdf:rest N8bf299d72cc4444792e6b6384756ae42
97 N3fb5cf54dd4040f6a6c6f8358deaca91 rdf:first sg:person.01020754724.52
98 rdf:rest N626c9cc88234408199815e37ee1fe964
99 N3fcbfb95feb64083bc79b4ea66957b5a rdf:first sg:person.01046155143.25
100 rdf:rest rdf:nil
101 N4a5cda1a25614ad4b01d4924c7597b8d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Drug Therapy, Combination
103 rdf:type schema:DefinedTerm
104 N55c25ff4823f46178bff8013907dcaa1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Hepatitis B e Antigens
106 rdf:type schema:DefinedTerm
107 N626c9cc88234408199815e37ee1fe964 rdf:first sg:person.0755456160.25
108 rdf:rest Naafec0f061dc4b78a57a0a6e0639db45
109 N6a3f1f9a588f4027909f82c0a13988b0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Male
111 rdf:type schema:DefinedTerm
112 N6d445c7a46d54f6b8ff27577935ef673 schema:name doi
113 schema:value 10.1186/1471-230x-14-94
114 rdf:type schema:PropertyValue
115 N6ef7e046670b49a69f06fde2b5402550 schema:name readcube_id
116 schema:value c914dccf7b5d1a64d33cc06edf7dff28d195601d7d3835e187c1bf8d1984db86
117 rdf:type schema:PropertyValue
118 N810721aef8c94943bb812a2bd9b20da5 schema:volumeNumber 14
119 rdf:type schema:PublicationVolume
120 N8a3736451c1f40a3b05958de2bf09174 schema:name dimensions_id
121 schema:value pub.1042212885
122 rdf:type schema:PropertyValue
123 N8bf299d72cc4444792e6b6384756ae42 rdf:first sg:person.01320704465.59
124 rdf:rest N2e2230583c0249f4b61dff65a602a9eb
125 N907ecf4bc67a4d91a176de38bea2a7a4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Treatment Outcome
127 rdf:type schema:DefinedTerm
128 N915f2d8296cf4d82b8961cba8a745862 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Guanine
130 rdf:type schema:DefinedTerm
131 Naa547ca852f7475fb360e20c3d2a6de1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Hepatitis B Surface Antigens
133 rdf:type schema:DefinedTerm
134 Naafec0f061dc4b78a57a0a6e0639db45 rdf:first sg:person.0736357351.35
135 rdf:rest N0b342ab98d3d49cfa1c40118042b9266
136 Nb33fa6e1151b4b99ad3c7fcba24fd86b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Antiviral Agents
138 rdf:type schema:DefinedTerm
139 Nb4f8170048ff44e39824c4185b9c9b13 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Organophosphonates
141 rdf:type schema:DefinedTerm
142 Nbcfd8d0c0871485da08831b0ef39c0f2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Interferon-alpha
144 rdf:type schema:DefinedTerm
145 Nca3672b60ab449b09a1cf646475e8eef schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Hepatitis B Antibodies
147 rdf:type schema:DefinedTerm
148 Nd3c2102d14014c439fe818fdcd66befb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Hepatitis B, Chronic
150 rdf:type schema:DefinedTerm
151 Nfe1c4ab4854b45b0b6e8614e027d2aa9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Recombinant Proteins
153 rdf:type schema:DefinedTerm
154 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
155 schema:name Medical and Health Sciences
156 rdf:type schema:DefinedTerm
157 anzsrc-for:1108 schema:inDefinedTermSet anzsrc-for:
158 schema:name Medical Microbiology
159 rdf:type schema:DefinedTerm
160 sg:journal.1024942 schema:issn 1471-230X
161 schema:name BMC Gastroenterology
162 rdf:type schema:Periodical
163 sg:person.01004120050.35 schema:affiliation https://www.grid.ac/institutes/grid.9657.d
164 schema:familyName Gallo
165 schema:givenName Paolo
166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01004120050.35
167 rdf:type schema:Person
168 sg:person.01020754724.52 schema:affiliation https://www.grid.ac/institutes/grid.9657.d
169 schema:familyName Galati
170 schema:givenName Giovanni
171 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01020754724.52
172 rdf:type schema:Person
173 sg:person.01046155143.25 schema:affiliation https://www.grid.ac/institutes/grid.9657.d
174 schema:familyName Picardi
175 schema:givenName Antonio
176 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046155143.25
177 rdf:type schema:Person
178 sg:person.01174604772.21 schema:affiliation https://www.grid.ac/institutes/grid.419423.9
179 schema:familyName Vincenti
180 schema:givenName Donatella
181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174604772.21
182 rdf:type schema:Person
183 sg:person.01272064356.26 schema:affiliation https://www.grid.ac/institutes/grid.9657.d
184 schema:familyName Dell’Unto
185 schema:givenName Chiara
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272064356.26
187 rdf:type schema:Person
188 sg:person.01320704465.59 schema:affiliation https://www.grid.ac/institutes/grid.419423.9
189 schema:familyName Solmone
190 schema:givenName Maria Carmela
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320704465.59
192 rdf:type schema:Person
193 sg:person.0736357351.35 schema:affiliation https://www.grid.ac/institutes/grid.9657.d
194 schema:familyName Vespasiani-Gentilucci
195 schema:givenName Umberto
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0736357351.35
197 rdf:type schema:Person
198 sg:person.0755456160.25 schema:affiliation https://www.grid.ac/institutes/grid.9657.d
199 schema:familyName De Vincentis
200 schema:givenName Antonio
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0755456160.25
202 rdf:type schema:Person
203 https://app.dimensions.ai/details/publication/pub.1077654954 schema:CreativeWork
204 https://app.dimensions.ai/details/publication/pub.1081694921 schema:CreativeWork
205 https://doi.org/10.1002/hep.510300511 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026634474
206 rdf:type schema:CreativeWork
207 https://doi.org/10.1016/0168-8278(95)80226-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037903619
208 rdf:type schema:CreativeWork
209 https://doi.org/10.1016/j.virol.2007.05.012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016357280
210 rdf:type schema:CreativeWork
211 https://doi.org/10.1016/s1386-6532(02)00049-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016035813
212 rdf:type schema:CreativeWork
213 https://doi.org/10.1046/j.1365-2893.1999.00160.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1051062831
214 rdf:type schema:CreativeWork
215 https://doi.org/10.1053/j.gastro.2012.05.037 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053089951
216 rdf:type schema:CreativeWork
217 https://doi.org/10.1056/nejmoa020681 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027660106
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1073/pnas.88.10.4186 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019592616
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1086/513200 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022757619
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1111/j.1478-3231.2007.01480.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1042066104
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1128/jvi.02011-08 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021168978
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1128/jvi.80.6.2968-2975.2006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037926878
228 rdf:type schema:CreativeWork
229 https://doi.org/10.4065/82.8.967 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001585719
230 rdf:type schema:CreativeWork
231 https://doi.org/10.7326/0003-4819-119-4-199308150-00011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073697674
232 rdf:type schema:CreativeWork
233 https://www.grid.ac/institutes/grid.419423.9 schema:alternateName Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani
234 schema:name National Institute for Infectious Diseases “Lazzaro Spallanzani”, 292 Portuense Street, 00149, Rome, Italy
235 rdf:type schema:Organization
236 https://www.grid.ac/institutes/grid.9657.d schema:alternateName Università Campus Bio-Medico
237 schema:name Clinical Medicine and Hepatology Unit, Campus Bio Medico University of Rome, 200, Alvaro Del Portillo Street, 00128, Rome, Italy
238 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...